ArticleVaccines2023

A Comprehensive Molecular and Clinical Investigation of Approved Anti-HCV Drugs Repurposing against SARS-CoV-2 Infection: A Glaring Gap between Benchside and Bedside Medicine.

Sneha Bansode et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.